Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms

Abstract excerpt

Although the first line of therapy for epithelial ovarian cancer typically consists of taxane-platinum combination therapy, many patients develop a platinum-resistant tumor within a year. Several previous studies have looked at this cross-resistance between cisplatin and anti-microtubule drugs, but their findings have been somewhat conflicting. Here, we developed cisplatin-resistant cell lines that are resistant...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics, phytochemicals, and oxidative stress
• Share to Microtubule and mitosis dynamics
• Share to Ovarian cancer diagnosis and treatment